Total Payments
$118,704
2024 Payments
$360.09
Companies
32
Transactions
418
Medicare Patients
7,849
Medicare Billing
$742,504
Payment Breakdown by Category
Other$98,310 (82.8%)
Food & Beverage$14,280 (12.0%)
Travel$4,635 (3.9%)
Consulting$1,284 (1.1%)
Education$194.54 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $98,310 | 35 | 82.8% |
| Food and Beverage | $14,280 | 345 | 12.0% |
| Travel and Lodging | $4,635 | 24 | 3.9% |
| Consulting Fee | $1,284 | 2 | 1.1% |
| Education | $194.54 | 12 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $86,927 | 105 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22,410 | 27 | $0 (2019) |
| BIOTRONIK INC. | $1,538 | 31 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,120 | 48 | $0 (2024) |
| Boston Scientific Corporation | $875.94 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $818.22 | 23 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $750.95 | 21 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $537.67 | 16 | $0 (2019) |
| Amgen Inc. | $526.54 | 19 | $0 (2023) |
| PFIZER INC. | $306.25 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.09 | 8 | Lexicon Pharmaceuticals, Inc. ($170.41) |
| 2023 | $766.90 | 12 | Amgen Inc. ($150.00) |
| 2022 | $353.70 | 8 | AstraZeneca Pharmaceuticals LP ($140.61) |
| 2021 | $277.48 | 3 | BIOTRONIK INC. ($261.37) |
| 2020 | $10,862 | 27 | Amarin Pharma Inc. ($10,366) |
| 2019 | $38,457 | 116 | Amarin Pharma Inc. ($33,879) |
| 2018 | $44,148 | 135 | Amarin Pharma Inc. ($31,437) |
| 2017 | $23,479 | 109 | Amarin Pharma Inc. ($11,245) |
All Payment Transactions
418 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $11.68 | General |
| 11/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $11.25 | General |
| 09/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $141.85 | General |
| 08/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.96 | General |
| 08/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $7.50 | General |
| 05/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $124.02 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology | ||||||
| 10/05/2023 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $136.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/04/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $117.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $121.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $46.90 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/23/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $83.18 | General |
| Category: Cardiovascular Device | ||||||
| 12/15/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2022 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/10/2022 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Soft Contact Lenses | ||||||
| 10/13/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $99.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/21/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $140.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,479 | 2,264 | $729,676 | $174,382 |
| 2022 | 24 | 1,862 | 2,678 | $724,945 | $183,652 |
| 2021 | 24 | 2,413 | 3,364 | $758,560 | $199,106 |
| 2020 | 22 | 2,095 | 2,895 | $712,238 | $185,363 |
Total Patients
7,849
Total Services
11,201
Medicare Billing
$742,504
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 250 | 505 | $108,070 | $40,050 | 37.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 48 | 50 | $125,000 | $20,606 | 16.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 88 | 95 | $95,000 | $17,391 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 150 | $48,150 | $16,963 | 35.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 248 | $55,362 | $16,871 | 30.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 103 | $61,800 | $15,416 | 24.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 48 | 100 | $14,200 | $9,523 | 67.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 105 | 117 | $43,056 | $7,122 | 16.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 31 | 128 | $64,000 | $5,520 | 8.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 279 | 412 | $31,724 | $5,328 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $12,519 | $3,746 | 29.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 45 | 45 | $14,241 | $2,888 | 20.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 14 | 15 | $10,440 | $2,672 | 25.6% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 36 | 41 | $18,327 | $2,424 | 13.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 18 | $5,778 | $1,963 | 34.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $3,000 | $1,511 | 50.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 14 | 19 | $4,750 | $1,401 | 29.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 49 | 50 | $4,437 | $919.50 | 20.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $1,100 | $791.56 | 72.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 49 | 50 | $2,939 | $612.50 | 20.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 15 | 24 | $3,384 | $520.27 | 15.4% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 11 | 12 | $2,400 | $142.68 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 245 | 504 | $107,856 | $41,117 | 38.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 39 | 40 | $100,000 | $18,165 | 18.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 86 | 91 | $91,000 | $17,655 | 19.4% |
About Dr. Joseph Tartaglia, MD
Dr. Joseph Tartaglia, MD is a Cardiovascular Disease healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649359381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Tartaglia, MD has received a total of $118,704 in payments from pharmaceutical and medical device companies, with $360.09 received in 2024. These payments were reported across 418 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($98,310).
As a Medicare-enrolled provider, Tartaglia has provided services to 7,849 Medicare beneficiaries, totaling 11,201 services with total Medicare billing of $742,504. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location White Plains, NY
- Active Since 11/03/2006
- Last Updated 01/14/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649359381
Products in Payments
- Vascepa (Drug) $86,927
- PRADAXA (Drug) $22,268
- ENTRESTO (Drug) $986.23
- XARELTO (Drug) $983.72
- BRILINTA (Drug) $798.46
- ELIQUIS (Drug) $711.66
- WATCHMAN (Device) $469.05
- Repatha (Biological) $268.88
- Corlanor (Drug) $253.66
- Livalo (Drug) $228.03
- PRALUENT (Biological) $200.37
- BYSTOLIC (Drug) $180.11
- LifeVest (Device) $176.98
- Pacemakers (Device) $173.89
- BioMonitor (Device) $143.90
- JARDIANCE (Drug) $142.05
- VERQUVO (Drug) $139.35
- LEQVIO (Drug) $133.97
- MULTAQ (Drug) $129.14
- Inpefa (Drug) $124.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in White Plains
Dr. Dimitrios Bliagos, M.d, M.D
Cardiovascular Disease — Payments: $46,317
Cardiovascular Disease $46,317
Dr. Jeffrey Shapiro, Md, MD
Cardiovascular Disease — Payments: $7,028
Cardiovascular Disease $7,028
Dr. Joshua Latzman, M.d, M.D
Cardiovascular Disease — Payments: $4,036
Cardiovascular Disease $4,036
Dr. Ronald Preston, Md, MD
Cardiovascular Disease — Payments: $3,736
Cardiovascular Disease $3,736
Dr. Monica Reynolds, Md, MD
Cardiovascular Disease — Payments: $3,013
Cardiovascular Disease $3,013
Dr. Latha Thanneer, Md, MD
Cardiovascular Disease — Payments: $2,064
Cardiovascular Disease $2,064